Oral tetravalent rotavirus vaccine can be successfully coadministered with oral poliovirus vaccine and a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine

Pediatric Infectious Disease Journal

Volumn 17, Issue 10, 1998, Pages 913-918

  Markwick, Alison J ^a,c   Rennels, Margaret B ^b   Zito, Edward T ^a   Wade, Mark S ^a   Mack, Michael E ^a  

^a WYETH AYERST RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c NONE   (United Kingdom)

Author keywords

Coadministration; Diphtheria; Haemophilus influenzae type b; Interference; Pertussis; Poliovirus; Rotavirus vaccine; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE;

ANOREXIA; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BORDETELLA PERTUSSIS; COMBINATION CHEMOTHERAPY; DIPHTHERIA; DOSE RESPONSE; DRUG SAFETY; FEMALE; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; SEROCONVERSION; TETANUS; VIRUS INFECTION; WHEEZING;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOUBLE-BLIND METHOD; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; POLIOVIRUS VACCINE, ORAL; ROTAVIRUS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED; VACCINES, COMBINED; VIRAL VACCINES;

EID: 0031734069     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199810000-00013     Document Type: Article

References (27)

1. Kapikian AZ, Flores J, Hoshino Y, et al. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controlled by a "Jennerian" approach to vaccination. J Infect Dis 1986;153:815-22, 1986.
2. Glass RI, Kilgore PE, Holman RC, et al. The epidemiology of rotaviras diarrhea in the United States: surveillance and estimates of disease burden. J Infect Dis 1996;174(Suppl 1):S5-11.
3. Middleton PJ, Syzmanski MT, Petric M. Viruses associated with acute gastroenteritis in young children. Am J Dis Child 1977;131:733-7.
4. Ryder RW, McGowan JE Jr, Hatch MH, Palmer EL. Reovirus-like agent as cause of nosocomial diarrhea in infants. J Pediatr 1977;90:698-702.
5. Midthun K, Hoshino Y, Kapikian AZ, Chanock RM. Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. J Clin Microbiol 1986;24:822-6.
6. Perez-Schael I, Blanco M, Vilar M, et al. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants. J Clin Microbiol 1990;28:553-8.
7. Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: report of the national multicenter trial. Pediatrics 1996;97:7-13.
8. Santosham M, Moulton LH, Reid R, et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr 1997;131.: 632-8.
9. Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997;350:1205-9.
10. Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997;337:1181-7.
11. King GE, Hadler SC. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J 1994;13:394-407.
12. Ward RL, Bernstein DI, Shukla R, et al. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis 1989;159:79-88.
13. Knowlton DR, Spector DM, Ward RL. Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Methods 1991;33:127-34.
14. Anderson P. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type b. J Immunol 1978;120:866-70.
15. Farr RS. A quantitative immunochemical measure of the primary interaction between I*BSA and antibody. J Infect Dis 1958;102:239-62.
16. Camargo ME, Silveira L, Furuta JA, Oliveira EPT, Germek OA. Immunoenzymatic assay of anti-diphtheria toxin antibodies in human serum. J Clin Microbiol 1984;20:772-4.
17. Melville-Smith M, Balfour A. Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralization test. J Med Microbiol 1988;25:279-83.
18. Melville-Smith ME, Seagroatt VA, Watkins JT. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 1983;11:137-44.
19. Karpinski K. F, Hayward S, Tryphonas H. Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA). J Immunol Methods 1987;103:189-94.
20. Expanded Program on Immunization report of a WHO informal consultation on polio neutralizing antibody assays, Nashville, 56-6-91. Document number: WHO/EPI/RD/91.3 REV1. Geneva: WHO, 1991.
21. Siber GR, Ransil BJ. Methods for the analysis of antibody responses to vaccines or other immune stimuli. Methods Enzymol 1983;93:60-78.
22. Reed GF, Meade BD, Steinhoff MC. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 1995;96:600-3.
23. Flores J, Perez-Schael I, Blanco M, et al. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine. J Clin Microbiol 1993;31:2439-45.
24. Paradiso PR, Hogerman DA, Madore DV, et al. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccine in young infants. Pediatrics 1993;92:827-32.
25. Rennels MB, Ward RL, Mack ME, Zito ET, for the US Rotavirus Vaccine Efficacy Group. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. J Infect Dis 1996;173:306-13.
26. Migasena S, Simasathien S, Samakoses R, et al. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants. Vaccine 1995;13:168-74.
27. Patriaca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991;13:926-39.